EA
Schedule 13G filing
Empery Asset Management, LP disclosed a 8.7% stake in Outlook Therapeutics, Inc. (OTLK)
Empery Asset Management, LP reported owning 8.7% of Outlook Therapeutics, Inc. (OTLK) (21,247,856 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 13, 2026
- Source
- Schedule 13G
More OTLK insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.